Plain-English translation of NCT07776509 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called AZD6234 to see if it works better than a placebo (dummy pill) when added to medications you may already be taking for weight management. The study includes adults who are overweight or have obesity, with or without type 2 diabetes, and who have at least one weight-related health condition like high blood pressure, heart disease, or sleep apnea. Researchers want to understand whether this medication, when combined with your current treatment, can help you lose weight more effectively and improve your overall health.
Current weight-loss medications help many people, but not everyone achieves the results they need. This trial is exploring whether adding the medication to existing treatments could provide better outcomes for people who have struggled with weight loss in the past.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either the new medication or a placebo pill, added to your current weight-loss medication regimen. You would continue your existing treatment at the same dose while taking the study medication (or placebo). The trial involves regular clinic visits for check-ups, blood tests, and weight measurements to monitor how the medication is working and ensure it is safe. The exact length of the study and visit schedule would be explained in detail during enrollment, but you would be closely monitored throughout.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
United States